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Background: Mobile health (mHealth) has the potential to bring preventive healthcare
within reach of populations with limited access to preventive services, by delivering
personalized support at low cost. Although numerous mHealth interventions are
available, very few have been developed following an evidence-based rationale or
have been tested for efficacy. This article describes the systematic development of a
coach-supported mHealth application to improve healthy lifestyles for the prevention of
dementia and cardiovascular disease in the United Kingdom (UK) and China.
Methods: Development of the Prevention of Dementia by Mobile Phone applications
(PRODEMOS) platform built upon the experiences with the Healthy Aging Through
Internet Counseling in the Elderly (HATICE) eHealth platform. In the conceptualization
phase, experiences from the HATICE trial and needs and wishes of the PRODEMOS
target population were assessed through semi-structured interviews and focus group
sessions. Initial technical development of the platform was based on these findings and
took place in consecutive sprint sessions. Finally, during the evaluation and adaptation
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phase, functionality and usability of the platform were evaluated during pilot studies in
UK and China.
Results: The PRODEMOS mHealth platform facilitates self-management of a healthy
lifestyle by goal setting, progress monitoring, and educational materials on healthy
lifestyles. Participants receive remote coaching through a chat functionality. Based on
lessons learned from the HATICE study and end-users, we made the intervention
easy-to-use and included features to personalize the intervention. Following the pilot
studies, in which in total 77 people used the mobile application for 6 weeks, the
application was made more intuitive, and we improved its functionalities.
Conclusion: Early involvement of end-users in the development process and during
evaluation phases improved acceptability of the mHealth intervention. The actual use
and usability of the PRODEMOS intervention will be assessed during the ongoing
PRODEMOS randomized controlled trial, taking a dual focus on effectiveness and
implementation outcomes.
Keywords: mHealth, dementia, cardiovascular disease(s), prevention, design concept, behavioral health

INTRODUCTION

risk (12). In this article, we describe the development of the
PRODEMOS mHealth intervention, from general idea to
platform design, and from prototype to pilot study. We make
specific recommendations on mHealth design for vulnerable
populations, based on extensive interactions with the target
population and other important stakeholders, including health
care professionals, software developers, and researchers.

The projected worldwide increase in dementia prevalence
is expected to largely occur in low- and middle-income
countries and amongst hard-to-reach populations in highincome countries (1, 2). An estimated 30–40% of late-life
dementia appears to be attributable to potentially modifiable
risk factors, including smoking, insufficient physical activity, and
unhealthy diet (3). Interventions targeting these risk factors may
have the potential to delay or prevent dementia onset and could
be especially beneficial for vulnerable populations, given their
high exposure to high risk of these behaviors (4, 5).
The rapid increase of internet access through mobile devices
may have the potential to bring preventive healthcare within
reach of large groups of people who have limited access to
preventive services (6). Mobile health (mHealth) applications
can contribute to personalized care and remote delivery of
health messaging and services, at low cost and on a global scale
(7, 8). Seizing the business opportunity healthcare applications
have mushroomed, rising to over 90 000 in app stores in
the first quarter of 2020 (9, 10). However, very few of these
have been developed following an evidence-based rationale, or
have been tested for efficacy in a (randomized controlled) trial.
While the conceptualization and architecture of such mHealth
interventions are key aspects of development with respect to its
perceived usability, uptake, and ultimately success, guidelines to
design mHealth interventions for vulnerable populations are not
readily available (11).
In the Prevention of Dementia using Mobile Phone
Applications (PRODEMOS) trial, we will assess the effectiveness
and implementation of a coach-supported mHealth platform
to reduce dementia risk over a period of 18 months. The
study population will consist of 1,200 older adults with low
socioeconomic status (SES) from the United Kingdom (UK)
and 1,200 older adults from Beijing, China, all with 2 or more
lifestyle factors at levels associated to an increased dementia
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METHODS
Context of PRODEMOS Study
The platform described in this paper was designed as part of the
PRODEMOS trial. Development of the PRODEMOS platform
built on the Healthy Aging Through Internet Counseling in
the Elderly (HATICE) eHealth platform, which was designed
and piloted between 2013 and 2016 and proven effective for
lowering cardiovascular risk amongst European older adults in a
randomized controlled trial (RCT) (13, 14). The coach-supported
HATICE platform enabled self-management of cardiovascular
risk factors, integrating European guideline recommendations
on prevention of cardiovascular disease (CVD) and principles
of Bandura’s social-cognitive theory of self-management and
behavioral change (15).
In PRODEMOS, we will focus on dementia prevention,
however, with up to 50% of modifiable risk factors for dementia
being cardiovascular risk factors we were still able to incorporate
experiences and evidence from the HATICE trial (3, 16, 17).
Given the rising smartphone penetration rates worldwide (18),
and because especially in LMIC people tend to access and use the
internet through smartphones rather than personal computers
(19), we decided to develop the PRODEMOS platform as an
mHealth intervention. The PRODEMOS platform is built to
facilitate the self-management of risk factors for dementia,
including overweight, hypertension, high cholesterol, diabetes,
unhealthy diet, smoking, and insufficient physical activity. In line
with the HATICE platform, PRODEMOS participants are able to
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application. Initial technical development was undertaken by
Philips Vital Health (PVH; for the UK) and Fuzhou Comvee
Network & Technology (Comvee; for China) in 2-weekly “sprint”
sessions over 4–6 months, according to the agile principle (22).
In iterative cycles, researchers from the coordinating research
team at Amsterdam UMC provided detailed descriptions of all
desired functionalities and gave feedback on functionalities that
were newly developed.

set SMART (Specific, Measurable, Achievable, Realistic, Timely)
lifestyle goals, enter measurements, read goal-related education
materials, and receive personalized lifestyle- and goal setting
support via chat messaging from a remote coach.
The mobile application will be connected to a coach portal,
allowing for remote lifestyle support by a health coach. The
PRODEMOS platform also comprises a separate assessor- and
researcher portal for data collection and outcome assessment,
and a static mobile application with written healthcare advice
only and without interactive features, for those randomized to
the control condition of the trial. The assessor- and researcher
portals and control application have been designed within the
research context of the PRODEMOS project, of which the
protocol is described in more detail elsewhere (12). Figure 1
shows the components of the PRODEMOS platform and their
interrelationships. All key functionalities of the PRODEMOS
platform will be similar in the UK and China. Besides differences
in language, certain cultural adaptations will be made to ensure
adequate fit of the intervention with the target population.
The PRODEMOS mobile application will be built to support
participants with limited digital literacy, operationalized as at
least being able to send a message using a smartphone.

Evaluation and Adaptation
Following initial technical development, the functionality of
the portal and mobile application were meticulously evaluated.
Software experts from PVH and Comvee and researchers from
the coordinating research team, UK, and China internally
tested the software. During “thinking aloud” sessions, we asked
potential participants to navigate through the mobile application
and directly share their thoughts with the developers. The
developers also tested user experience (i.e., how the participants
interact with the mobile application) and the user interface (i.e.,
the look and feel, presentation, and interactivity of the mobile
application) with potential participants using predefined scripts
and success criteria for participants to navigate through the most
important functionalities of the application. The functionality of
the portal and mobile application was subsequently trialed in sixweek pilot studies in the UK and China. We used qualitative
data, gathered through focus groups with pilot participants and
participating coaches, and data on user statistics to evaluate
usability. User statistics included details on goals, measurements,
and chat history and were gathered manually from the platform,
as the automated export functionality for user statistics had not
been finalized by that stage. Findings from the internal test
sessions, thinking aloud session, and pilot evaluation informed
the final adaptation phase, in which the portal and mobile
application was prepared for use in the full trial.
Unless stated otherwise, all qualitative sessions were led
by at least one member of the research team and one
member of the technical team, following a topic guide. We
audiotaped all sessions and shared written summaries with
the coordinating research team. Through plenary discussions
between the researchers and technical developers, we translated
the evaluation results into concrete development steps when
deemed appropriate and feasible. More detail on demographics,
methodology and recruitment of the evaluation processes is
provided in Supplementary Table 1.

Phases of Development
The development of the PRODEMOS platform is visualized
in Figure 2. Although technical interventions are typically
developed in an iterative cycle of overlapping phases, several
distinct phases can be distinguished in the development of the
PRODEMOS platform.

Conceptualization
First, we performed a thorough evaluation of the HATICE
platform, focusing on the perceived value and usability of the
eHealth intervention, as well as on the overall implementation.
Through thematic analysis of semi-structured interviews with
HATICE participants, we learned which factors affected initial
and sustained engagement with the eHealth platform (20). In
subsequent focus groups, we asked HATICE participants and
coaches to share their experiences, views and recommendations
for future use of the platform and coach support.
Following this, we assessed the specific needs and wishes
of the PRODEMOS target population regarding an mHealth
intervention to change their lifestyle behavior. We performed
semi-structured interviews with 19 low SES Dutch older adults
and 26 Chinese older adults and thematically analyzed them (21).
To gather further data on the needs of the target population
for successful use of the platform and remote coaching,
focus group sessions with older adults of low SES were held
in both the UK and the Netherlands. In separate sessions,
other stakeholders, including Clinical Research Network nurses
and experienced health coaches, were interviewed about their
perspectives regarding coach-support for vulnerable populations.

RESULTS
Conceptualization Phase
Lessons Learned From the HATICE Study
Prior to the start of the development of the PRODEMOS
mHealth portal and mobile application construction, a
qualitative evaluation among participants and coaches of
the HATICE intervention took place. This demonstrated that
most participants had appreciated the HATICE platform and
coach support, and felt that it had helped them to pursue their
lifestyle goals. Participants had used the platform mostly in a
reactive way, by responding to notifications about chat messages

Initial Technical Development
Based on the HATICE eHealth platform and the additional
lessons learned, the study group drafted an outline capturing
all necessary functionalities for the new portal and mobile
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FIGURE 1 | Overview of the PRODEMOS platform and its interactions.

FIGURE 2 | Phases of development of the PRODEMOS platform.

tailor the intervention to (changes in) their personal situation.
As a response, we developed several additional features to
facilitate personalization of the intervention, as displayed in
Supplementary Table 2. Some HATICE participants noted that
they had rarely used several functionalities of the intervention
and thought that additional guidance, e.g., by adding a tutorial
video on the home page, could help participants to make
more use of all features of the platform. We therefore built an

and questionnaires (20). To capitalize on this finding, more
(automatic) reminders to enter measurements were built in
to the PRODEMOS mobile application, the frequency and
content of which can be adjusted to the participant’s needs.
The qualitative evaluation of HATICE also revealed that
participants had a wish for more tailored and frequently updated
education material to stimulate sustained engagement over
time. Furthermore, they expressed a need for more options to
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short term (e.g., losing weight to fit in their favorite jeans rather
than to prevent future chronic disease; 63 year old male interview
participant “[. . . ]I can hardly tie my shoelaces. And look, that
annoys the hell out of me. But now I’ve been wearing slippers
for 3 months [. . . ]so now I’m not annoyed. And soon I’m gonna
have to wear my shoes again, and maybe that will cause to flip
a switch.”). Also, members from the target group mentioned
that lifestyle advice should be tailored to their personal situation.
As we learned that Chinese elderly often perform tai chi or
square dancing (i.e., low-key dancing groups on public squares)
in order to stay active, we included corresponding options to
the Chinese mobile application. A comprehensive overview of
adaptations made to the mobile application based on input
from the PRODEMOS target population can be found in
Supplementary Table 2.

explanatory animation video accessible through the library of
the mobile application, covering the main functionalities of the
PRODEMOS application.
From the HATICE trial, we learned that coach support was
very important to stimulate both initial and sustained platform
use. Participants expressed a need for active encouragement from
the coach when a goal was reached or when their commitment
weakened. Similarly, as HATICE coaches would have liked to
keep better track of their participants’ progress, we redesigned
certain functionalities of the coach portal to facilitate better
support of participants, as shown in Supplementary Table 2.

Lessons Learned From Potential PRODEMOS
End-Users
Input from focus group sessions and individual interviews with
older adults at increased cardiovascular risk in China and of
additional low SES in the Netherlands and the UK, and focus
groups with healthcare professionals in the UK and China was
used to tailor the intervention to the PRODEMOS end-users. For
the current section, we distinguish aspects of user-friendliness
and personalization of the PRODEMOS mobile application.

Technical Development
Following the lessons learned, technical development of the
UK platform commenced in April 2019. In accordance with
the project planning, development in China started in July
2020. Due to differences in hosting requirements between the
countries, both platforms were developed and hosted in separate
environments in the UK and China. As mentioned previously,
both platforms were developed based on the same concepts
and requirements, with certain cultural adaptations wherever
deemed necessary.
The development of the platforms followed an iterative
process, allowing for timely redirection and adaptations.
Development was evaluated every other week with the European
and Chinese software developers. To bridge the gap between
(medical) researchers and technical developers, we used
storyboards, containing user-stories, and functional flow
block diagrams, mapping all connections between the coach
portal and the mobile application. The platform and mobile
application were ready for preliminary internal testing by the
developers and coordinating research team 5 months after
the initial start of development. An overview of the basic
functionalities of the PRODEMOS application can be found in
Supplementary Figure 1.

User-Friendliness
As previously mentioned by the HATICE participants, members
of the target population expressed the desire for a simple and
intuitive-to-use mobile application, for example as suggested by
a 77 year old male interview participant: “If you’re going to
introduce this [app], you’d really have to educate a group of people,
like how do you use something like that?.” Both potential coaches
and participants favored pre-set options for lifestyle goals, to
ensure easy-to-achieve and feasible goals. We developed the goalsetting flow in such a way that participants are able to build
their lifestyle goals in several consecutive steps with wide choice
from pre-set options, using the SMART principle (e.g., losing
weight by increasing physical activity levels by walking twice
a week for 30 mins). Participants also indicated the need for
positive framing (e.g., ‘improving blood pressure’ as opposed
to ‘working on high blood pressure’) and easy (non-medical)
language, for example a 63 year old female interview participant:
“[The app has to be] understandable! Don’t go tossing around
big words and medical terms and all that.” For this, we have
adapted the wording throughout the mobile application. Another
important aspect of a user-friendly intervention was trustworthy
and easy-to-understand material. Lastly, we have simplified login procedures, to facilitate easy access (Supplementary Table 2).
Based on wishes from the Chinese target population, we made
the Chinese mobile application available as a WeChat subapplication or “mini-program.” WeChat is a widely used Chinese
multi-purpose messaging, social media, and mobile payment
application with a wide range of such mini-programs.

Evaluation and Adaptation Phase
Internal Testing
After internal testing by the technical developers, the software
was meticulously tested by the coordinating research team
to detect potential technical issues, e.g., software bugs. One
or more software developers were present during these test
sessions to immediately investigate encountered issues and to
deliver technical support where needed. After several test cycles,
researchers and health coaches from the British and Chinese
teams gained access to the mobile application and coach portal
to interactively test the system over a longer period of time. The
majority of findings concerned software bugs that had to do with
the interaction between the mobile application and coach portal.
Findings were recorded in a living document. After prioritization
on relevance, urgency, and feasibility in collaborative sessions,
findings were resolved by the software developers.

Personalization
In addition to user-friendliness, personalization of and flexibility
during the intervention were regarded important aspects of
(digital) lifestyle support. We learned from interviews with
members of the target population that their lifestyle goals are
often very specific, person-related, and result-driven on the
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User Test and Pilot

Involving potential end-users in the development process
is thought to result in a more appropriate platform design
(23–26). To optimally benefit from the feedback of (potential)
end-users, we think the timing of these evaluation sessions is
of great importance. Early involvement of end-users may be
ideal, giving the developers sufficient time to optimally translate
feedback into platform development. However, we learned
that obtaining specific feedback on platform functionalities in
the early stages can be very challenging for potential endusers, given its theoretical and conceptual rather than practical
setting. Demonstrating a prototype of the platform, by using
clickable designs and wireframes, can make these concepts more
tangible, probably increasing the yield of end-user involvement
in platform development. User testing of the preliminary
functionalities through thinking aloud sessions greatly improved
our insights in potential pitfalls of the platform and allowed for
early adaptations. Our experience was that the direct presence of
software developers during these sessions can benefit the usercentered design process, resulting in more mutual understanding
and, ultimately, greater efficiency and quality.

After internal testing, the platforms were evaluated through
thinking aloud sessions and pilot studies. The thinking aloud
session provided good insight into the (intuitive) handling of the
mobile application by our target population. Findings yielded
mostly suggestions to further improve its usability and userfriendliness. Subsequently, the mobile application and portal
were tested in a six-week pilot study in both the UK (n = 21)
and China (n = 56). This way, we gained information about
frequently used and potentially neglected functionalities and
options in the app (e.g., goals were often set by sending chat
messages to the coach rather than by using the goal-setting
engine; the library was often overlooked).
In the UK, participants indicated the need for more intuitive
operationalization of the mobile application with a consistent
user interface. Text density and font size needed to be adjusted
to better suit the target population. Moreover, log-in procedures
were often found to be too complex. In China, as there is already a
lot of information available on WeChat, participants stressed the
need for more in-depth education material.
Coaches in the UK expressed the need to further improve
the graphical overview of the progress of participants. Moreover,
coaches felt like they would be able to support participants
better if they were able to help participants with their goal
setting by adjusting certain aspects, such as the evaluation
date or the goal target, to make the goals more achievable
or relevant. Additionally, coaches in China indicated the
need for more extensive instructional information explaining
the mobile application and coach portal. A more detailed
description of adaptations made to the mobile application
and platform based on the evaluation findings is displayed in
Supplementary Table 2.

Limitations
While the evidence-based development of the PRODEMOS
portal and mobile application provides exciting opportunities to
test the efficacy and implementation of an mHealth intervention
in vulnerable populations, we faced several limitations. During
focus groups, potential end-users expressed a wish for peer
contact and activities to initiate and sustain behavior change.
We have investigated the possibilities of incorporating this
in our platform, however, concluded that this would yield
too many complications regarding organization and privacy
regulation. A similar limitation was the integration of external
health monitoring devices and other health applications with
the PRODEMOS application. Due to the variety and rapidly
advancing technologies of smartphones and wearable sensors, we
could not ensure continued compatibility of these monitoring
tools and decided not to integrate them in our mobile application.
The PRODEMOS mobile application was specifically designed
for older, vulnerable populations, integrating a simple, intuitive
interface, with written and digital instruction manuals and
in-person familiarization with the mobile application, guided
by the health coach. However, it is conceivable that part of
the target population may not be able to overcome some
of the technological challenges involved in using the mobile
application. Additionally, to use the application, participants
need to have regular and affordable access to the internet.
Increasing smartphone possession and usage among older adults
suggests that this may be a decreasing barrier (27). Until this
barrier is completely omitted, mHealth should be complimentary
to alternative methods to facilitate behavior change in older
adults. Finally, mHealth is a rapidly advancing field, therefore it
is important to appraise the reported findings within the context
of this changing landscape of innovation, for example by taking
new software features and design trends into account (28).

DISCUSSION
In this paper, we describe the design, development, and piloting
of an mHealth portal and mobile application for the prevention
of dementia in the context of the PRODEMOS trial, building
upon the existing evidence and experience from the HATICE
eHealth platform. Based on extensive input from all stakeholders
involved, we developed a platform for behavior change for older
adults, with adaptations for specific needs from the low SES
population in the UK and the general population in China.
For the thorough development of an mHealth platform,
many stakeholders from several backgrounds need to be
involved, including researchers, healthcare professionals,
software developers, and the target population. We believe clear
communication is crucial to understand each other’s idioms
and ways of thinking during development and evaluation.
We identified several learning points for open and clear
communication between the involved parties. Structural (weekly)
meetings stimulated transmission of knowledge and updates on
progression. We believe this kept the whole team informed on
advancement and allowed timely redirection if necessary. During
these meetings, we kept structural documentation on wishes,
adaptations and platform errors.
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mHealth may recently have become an even more attractive
and desirable way to deliver interventions for risk factor
management and disease prevention, as the COVID-19
pandemic has highlighted the need for preventive care that
can be accessed remotely. Despite the increasing availability
of mHealth applications for the prevention of dementia
and cardiovascular disease, studies on the development,
implementation, and effectiveness of these platforms are scarce.
In order to demonstrate the added value of such technologies,
there is an urgent need for evidence-based mHealth interventions
and high-quality evaluation studies (29). We believe that when
developing such digital interventions, early involvement of
end-users and other stakeholders will likely aid success and
implementation. Moreover, development of a platform that
is sustainably used could benefit from consistency of team
members and documentation of all steps and decisions taken
during each phase of development.
The actual use and usability of the PRODEMOS intervention
will be assessed over the coming years in the PRODEMOS trial,
with a dual focus on effectiveness and implementation outcomes.
If effective, it likely increases the yield of preventive programs
in resource-poor settings. If implementable, it will contribute
to an improved understanding how such interventions may be
successfully provided in the real-world setting.
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